| COVID 3CL protease inhibitor |
| Ensitrelvir |
| Ensitrelvir (USAN/INN) |
| Ensitrelvir fumarate (USAN); Ensitrelvir fumaric acid (JAN) <JP> |
| Nirmatrelvir and ritonavir <JP/US> |
| Olgotrelvir |
| Olgotrelvir (USAN) |
| Olgotrelvir sodium (USAN) |
| Lufotrelvir (USAN) |
| Nirmatrelvir (JAN/USAN) |
| Pomotrelvir (USAN/INN) |
| Ibuzatrelvir (USAN) |
| Zevotrelvir (USAN/INN) |
| Remdesivir (JAN/USAN) <JP/US> |
| Molnupiravir (JAN/USAN) <JP/US> |
| Tixagevimab and cilgavimab |
| Sotrovimab (USAN/INN); Sotrovimab (genetical recombination) (JAN) <JP> |
| Regdanvimab (INN) |
| Casirivimab and imdevimab <JP> |
| Sipavibart (INN); Sipavibart (genetical recombination) (JAN) <JP> |
| Bamlanivimab (USAN) |
| Etesevimab (USAN) |
| Bebtelovimab (USAN) |
| Bemnifosbuvir |
| Bemnifosbuvir (USAN) |
| Bemnifosbuvir sulfate (USAN) |
| Casirivimab (USAN); Casirivimab (genetical recombination) (JAN) |
| Imdevimab (USAN); Imdevimab (genetical recombination) (JAN) |
| Tixagevimab (USAN); Tixagevimab (genetical recombination) (JAN) |
| Cilgavimab (USAN); Cilgavimab (genetical recombination) (JAN) |
| Plutavimab (USAN) |
| Amubarvimab (USAN) |
| Romlusevimab (USAN) |
| Beludavimab (USAN) |
| Crexavibart (USAN/INN) |
| Ogalvibart (USAN/INN) |
| Adintrevimab (USAN/INN) |
| Ensovibep (INN); Ensovibep (genetical recombination) (JAN) |
| Gorivitug (USAN/INN) |
| Obeldesivir (JAN/USAN/INN) |
| Pemivibart (USAN/INN) <US> |
